Image

Multiple myeloma

About
Risks
Symptoms
Diagnosis
Prevention

Multiple myeloma is a type of blood cancer that arises from plasma cells, a kind of white blood cell responsible for producing antibodies. In this condition, malignant plasma cells accumulate in the bone marrow, leading to disruptions in normal blood cell production and immune function. As the cancer progresses, it can cause damage to bones, kidneys, and other organs, significantly impacting a patient's health and quality of life.

Several factors may increase the likelihood of developing multiple myeloma, including older age, with most diagnoses occurring in individuals over 65 years of age. Other risk factors include a family history of the disease, certain pre-existing conditions like monoclonal gammopathy of undetermined significance (MGUS), and exposure to radiation or certain chemicals. Additionally, men are generally at a higher risk compared to women.

Multiple myeloma can present with a range of symptoms that might develop over time, including bone pain, fatigue, frequent infections, and anemia. Patients may also experience symptoms related to kidney dysfunction, such as increased thirst or urine output, as well as hypercalcemia, which can lead to nausea and confusion. As the disease progresses, symptoms may become more severe or lead to complications such as fractures or neurological issues.

Multiple myeloma is primarily caused by the abnormal growth of plasma cells, a type of white blood cell responsible for producing antibodies. The exact cause of this uncontrolled growth remains unclear, but it is associated with various risk factors, including age, genetic predispositions, and exposure to certain chemicals or radiation. Conditions such as monoclonal gammopathy of undetermined significance (MGUS) can precede multiple myeloma and indicate an increased risk of developing this malignancy.

The diagnosis of multiple myeloma typically involves a combination of clinical evaluation, blood tests, and imaging studies. Common diagnostic tests include serum protein electrophoresis to identify abnormal antibodies, a complete blood count to assess blood cell levels, and bone marrow biopsy to confirm the presence of malignant plasma cells. Imaging techniques like X-rays, MRIs, or CT scans are used to evaluate bone integrity and detect lesions.

The treatment of multiple myeloma typically involves a combination of therapies, including chemotherapy, targeted therapy, and immunotherapy. Stem cell transplantation may also be considered for eligible patients to achieve remission. Additionally, supportive therapies such as bisphosphonates, pain management, and blood transfusions may be necessary to address complications arising from the disease.

Currently, there are no established strategies for preventing multiple myeloma, as its exact causes remain largely unknown. However, maintaining a healthy lifestyle through regular exercise, a balanced diet, and avoiding exposure to harmful substances may help reduce the overall risk. Furthermore, individuals with risk factors, such as a family history or prior MGUS diagnosis, should engage in regular medical check-ups for early detection and monitoring.
On this page